BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 6295071)

  • 1. Increased excretion of urinary cyclic GMP in primary hepatoma and preneoplastic liver.
    Shimamura J; Taketa K; Ito T; Shimada Y; Nagashima H
    Acta Med Okayama; 1982 Oct; 36(5):331-40. PubMed ID: 6295071
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cyclic nucleotides in biological fluids in hepatocellular carcinoma.
    Dusheiko GM; Levin J; Kew MC
    Cancer; 1981 Jan; 47(1):113-8. PubMed ID: 6257369
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Plasma clearance rates and renal clearance of 3H-labeled cyclic AMP and 3H-labeled cyclic GMP in the dog.
    Blonde L; Wehmann RE; Steiner AL
    J Clin Invest; 1974 Jan; 53(1):163-72. PubMed ID: 4357610
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Urinary excretion of cyclic adenosine 3',5'-monophosphate and cyclic guanosine 3',5'-monophosphate in malignancy.
    Gennari C; Francini G; Galli M; Lore F
    J Clin Pathol; 1978 Aug; 31(8):735-41. PubMed ID: 211147
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Deranged metabolism of cyclic nucleotides in liver diseases.
    Matsushima T; Maekubo H; Yoshida T; Taneda H; Yoshida J; Miyazaki T; Okada F
    Horm Metab Res; 1985 Jun; 17(6):306-7. PubMed ID: 2991101
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Plasma and urine cyclic nucleotide levels in malignant disease and cirrhosis of the liver.
    Wood PJ; Ross G; Smith CL
    J Clin Pathol; 1979 Oct; 32(10):998-1002. PubMed ID: 230205
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Increased urinary excretion of cyclic guanosine monophosphate in rats bearing Morris hepatoma 3924A.
    Murad F; Kimura H; Hopkins HA; Looney WB; Kovacs CJ
    Science; 1975 Oct; 190(4209):58-60. PubMed ID: 170677
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Urinary cyclic adenosine 3',5'-monophosphate (cAMP) and cyclic guanosine 3',5'-monophosphate (cGMP) in asthmatic and normal children.
    König P; Carpenter M; White AA
    Eur J Respir Dis; 1980 Aug; 61(4):218-26. PubMed ID: 6258958
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Enhanced urinary excretion of cGMP in liver cirrhosis. Relationship to hemodynamic changes, neurohormonal activation, and urinary sodium excretion.
    Fernández-Rodriguez CM; Prieto J; Quiroga J; Zozaya JM; Andrade A; Rodriguez-Ortigosa C
    Dig Dis Sci; 1997 Jul; 42(7):1416-20. PubMed ID: 9246039
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Dynamics of urinary excretion of cyclic nucleotides in cancer patients during a long-term follow-up].
    Bershteĭn LM
    Vopr Onkol; 1987; 33(9):54-8. PubMed ID: 2821698
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Urinary cyclic GMP after treatment of gynecological cancer. A prognostic marker of clinical outcome.
    Orbo A; Hanevik M; Jaeger R; Van Heusden S; Sager G
    Anticancer Res; 2007; 27(4C):2591-6. PubMed ID: 17695420
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Urinary excretion of cyclic guanosine 3':5'-monophosphate and cyclic adenosine 3':5'-monophosphate in rats bearing transplantable liver and kidney tumors.
    Criss WE; Murad F
    Cancer Res; 1976 May; 36(5):1714-6. PubMed ID: 178429
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Urinary excretion of adenosine 3',5'-monophosphate and guanosine 3',5'-monophosphate in normal children and those with cystic fibrosis.
    Murad F; Moss WW; Johanson J; Selden RF
    J Clin Endocrinol Metab; 1975 Apr; 40(4):552-9. PubMed ID: 165210
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Increased guanylate cyclase activity and guanosine 3',5'-monophosphate content in ethionine-induced hepatomas.
    DeRubertis FR; Craven P
    Cancer Res; 1977 Jan; 37(1):15-21. PubMed ID: 11887
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Urinary cyclic AMP and cyclic GMP in normal and asthmatic subjects during exercise.
    Linklater HA; Strickland KP; Cunningham DA; Griffiths JC; Trevithick JR
    Med Sci Sports; 1979; 11(3):250-5. PubMed ID: 230405
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sources of cyclic nucleotides in plasma.
    Wehmann RE; Blonde L; Steiner AL
    J Clin Invest; 1974 Jan; 53(1):173-9. PubMed ID: 4357611
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of the effects of theophylline, prednisolone and sleep withdrawal on airway obstruction and urinary cyclic AMP/cyclic GMP excretion of asthmatic children with and without nocturnal asthma.
    Reinhardt D; Schuhmacher P; Fox A; Stemmann EA; Wegner F
    Int J Clin Pharmacol Ther Toxicol; 1980 Sep; 18(9):399-404. PubMed ID: 6256299
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Circadian rhythms in the urinary excretion of cyclic 3',5'-adenosine monophosphate (cyclic AMP) and cyclic 3',5'-guanosine monophosphate (cyclic GMP) in human subjects.
    Kopp L; Lin T; Tucci JR
    J Clin Endocrinol Metab; 1977 Apr; 44(4):673-80. PubMed ID: 191467
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bullatacin, a potent antitumor Annonaceous acetogenin, induces apoptosis through a reduction of intracellular cAMP and cGMP levels in human hepatoma 2.2.15 cells.
    Chiu HF; Chih TT; Hsian YM; Tseng CH; Wu MJ; Wu YC
    Biochem Pharmacol; 2003 Feb; 65(3):319-27. PubMed ID: 12527325
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Urinary excretion of cAMP and cGMP in bronchogenic carcinoma complicated by hypertrophic osteoarthropathy.
    Francini G; Nami R; Grossi A; Gennari C
    Panminerva Med; 1983; 25(1):19-21. PubMed ID: 6306543
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.